Publications That Use U.S. Cancer Statistics Data
Related Pages
U.S. Cancer Statistics data are used by CDC researchers, cancer registry program staff, academic and medical researchers, and others to advance scientific knowledge and reduce the burden of cancer. Stat bites, data briefs, and a selection of peer-reviewed journal articles using U.S. Cancer Statistics data are highlighted below.
Stat Bites
Current U.S. Cancer Statistics Data Briefs
- Incidence of Malignant Melanoma of the Skin–United States, 2009–2018 New
Number 28, May 2022 - Incidence of Malignant Mesothelioma, 1999–2018
Number 27, March 2022 - Cancers Associated with Human Papillomavirus, United States, 2014–2018
Number 26, December 2021 - Incidence and Relative Survival by Stage at Diagnosis for Common Cancers
Number 25, November 2021 - Incidence of Screening-Detectable Cancers Among Non-Hispanic American Indian and Alaska Native Populations 2014–2018 (Purchased/Referred Care Delivery Areas)
Number 24, November 2021 - United States Cancer Statistics: Highlights from 2018 Incidence
Number 23, June 2021
Selected Journal Articles
- Reece AS, Hulse GK. A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates.external icon BMC Cancer. 2021;21:197. 10.1186/s12885-021-07924-3external icon
- Turbow SD, White MC, Breslau ES, Sabatino SA. Mammography use and breast cancer incidence among older U.S. women.external icon Breast Cancer Research and Treatment. 2021. 10.1007/s10549-021-06160-4external icon
- Mix JM, Van Dyne EA, Saraiya M, Hallowell BD and Thomas CC. Assessing impact of HPV vaccination on cervical cancer incidence among women aged 15–29 years in the United States, 1999–2017: An ecologic study.external icon Cancer Epidemiology, Biomarkers and Prevention. 2021;30(1):30–37. 10.1158/1055-9965.EPI-20-0846external icon
- Ellington, TD, Henley, SJ, Wilson, RJ, Wu, M, Richardson, LC. Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial‐ethnic group, United States 2003–2016.external icon Cancer Medicine. 2021;10(1):386–395. 10.1002/cam4.3444external icon
- Boakye EA, Babatunde OA, Wang M, Osazuwa-Peters N, Jenkins W, Lee M, Kim M. Geographic variation in human papillomavirus vaccination initiation and completion among young adults in the U.S.external icon American Journal of Preventive Medicine. 2021;60(3):387–396. 10.1016/j.amepre.2020.09.005external icon
- Bartley SJ, Wu M, Benard V, Ambrosone C, Richardson LC. Are there regional differences in triple negative breast cancer among non-Hispanic Black women?external icon Journal of the National Medical Association. 2021;S0027-9684(17)30188-8. 10.1016/j.jnma.2020.07.016external icon
- Barlass U, Deshmukh A, Beck T, Bishehsari F. Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.external icon PLoS ONE. 2021;16(1):e0244285. 10.1371/journal.pone.0244285external icon
- Thrift AP, Gudenkauf FJ. Melanoma incidence among non-Hispanic Whites in all 50 US states from 2001 through 2015.external icon JNCI: Journal of the National Cancer Institute. 2020;112(5):533–539. 10.1093/jnci/djz153external icon
- Zhang X, El-Serag HB, Thrift AP. Sex and race disparities in the incidence of hepatocellular carcinoma in the United States examined through age-period-cohort analysis.external icon Cancer Epidemiology, Biomarkers and Prevention. 2020;29(1):88–94. 1158/1055-9965.EPI-19-1052external icon
- Thrift AP, El-Serag HB. Burden of gastric cancer.external icon Clinical Gastroenterology and Hepatology. 2020;18(3):534-542. 1016/j.cgh.2019.07.045external icon
- Tavakkoli, A, Singal, AG, Waljee, AK, Elmunzer BJ, Pruitt SL, T McKey, Rubenstein JH, Scheiman JM, Murphy CC. Racial disparities and trends in pancreatic cancer incidence and mortality in the United States.external icon Clinical Gastroenterology and Hepatology. 2020;18(1):171-178. 1016/j.cgh.2019.05.059external icon
- Siegel DA, O’Neil ME, Richards TB, Dowling NF, Weir HK. Prostate cancer incidence and survival, by stage and race/ethnicity—United States, 2001–2017. MMWR Morbidity and Mortality Weekly Report. 2020;69:1473–1480. 10.15585/mmwr.mm6941a1external icon
- Shah UA, Shah N, Qiao B, Acuna-Villaorduna A, Pradhan K, Adrianzen Herrera D, Sica RA, Shastri A, Mantzaris I, Derman O, Kornblum N, Braunschweig I, Ye BH, Verma A, Janakiram M. Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.external icon Cancer. 2020;126:567-574. 1002/cncr.32556external icon
- Paulson KG, Gupta D, Kim TS, Veatch JR, Byrd DR, Bhatia S, Wojcik K, Chapuis AG, Thompson JA, Madeleine MM, Gardner JM. Age-specific incidence of melanoma in the United States.external icon Journal of the American Medical Association Dermatology. 2020;156(1):57-64. 1001/jamadermatol.2019.3353external icon
- Khan N, Tomar SL. The incidence of oropharyngeal cancer and rate of human papillomavirus vaccination coverage in Florida, 2011 through 2015.external icon Journal of the American Dental Association. 2020;151(1):51-58. 1016/j.adaj.2019.08.022external icon
- Jemal A, Culp MB, Ma J, Islami F, Fedewa SA. Prostate cancer incidence 5 years after US Preventive Services Task Force recommendations against screening.external icon JNCI: Journal of the National Cancer Institute. 2020;113(1):64–71. 10.1093/jnci/djaa068external icon
- Iyengar S, Hall IJ, Sabatino SA. Racial/ethnic disparities in prostate cancer incidence, distant stage diagnosis, and mortality by U.S. census region and age-group, 2012-2015.external icon Cancer Epidemiology, Biomarkers and Prevention. 2020;1055-9965. 1158/1055-9965.EPI-19-1344external icon
- Henley SJ, Peipins LA, Rim SH, Larson TC, Miller JW. Geographic co-occurrence of mesothelioma and ovarian cancer incidence.external icon Journal of Women’s Health. 2020;29(1):111-118. 1089/jwh.2019.7752external icon
- Gopalani SV, Janitz AE, Martinez SA, Gutman P, Khan S, Campbell JE. Trends in cancer incidence among American Indians and Alaska Natives and non-Hispanic Whites in the United States, 1999–2015.external icon Cancer. 2020;31(2):205–213. 10.1097/EDE.0000000000001140external icon
- Ellington TD, Henley SJ, Wilson RJ, Miller JW. Breast cancer survival among males by race, ethnicity, age, geographic region, and stage—United States, 2007–2016. MMWR Morbidity and Mortality Weekly Report. 2020;69(41):1481–1484. 10.15585/mmwr.mm6941a2external icon
- Ellington TD, Henley SJ, Senkomago V, O’Neil ME, Wilson RJ, Singh S, Thomas CC, Wu M, Richardson LC. Trends in incidence of cancers of the oral cavity and pharynx—United States, 2007–2016. MMWR Morbidity and Mortality Weekly Report. 2020;69:433–438. 15585/mmwr.mm6915a1external icon
- Dong M, Cioffi G, Wang J, Waite KA, Ostrom QT, Kruchko C, Lathia JD, Rubin JB, Berens ME, Connor J, Barnholtz-Sloan JS. Sex differences in cancer incidence and survival: A pan-cancer analysis.external icon Cancer Epidemiology, Biomarkers and Prevention. 2020; 29(7):1389–1397. 10.1158/1055-9965.EPI-20-0036external icon
- Deshmukh AA, Suk R, Shiels MS, Damgacioglu H, Lin YY, Stier EA, Nyitray AG, Chiao EY, Nemutlu GS, Chhatwal J, Schmeler K, Sigel K, Sonawane K. Incidence trends and burden of human papillomavirus-associated cancers among women in the United States, 2001–2017.external icon JNCI: Journal of the National Cancer Institute. 2020;djaa128. 10.1093/jnci/djaa128external icon
- Das P, Soni P, Jones J, Habboub G, Barnholtz-Sloan JS, Recinos PF, Kshettry VR. Descriptive epidemiology of chordomas in the United States.external icon Journal of Neuro-oncology. 2020;148(1):173–178. 10.1007/s11060-020-03511-xexternal icon
- Culp MB, Benard V, Dowling NF, King J, Lu H, Rao C, Scott LC, Wilson R, Wu M. Ocular melanoma incidence rates and trends in the United States, 2001–2016.external icon Eye. 2021;35(2):687–689. 10.1038/s41433-020-0885-1external icon
- Alattas M, Ross CS, Henehan ER, Naimi TS. Alcohol policies and alcohol-attributable cancer mortality in U.S. states.external icon Chemico-Biological Interactions. 2020;315. 10.1016/j.cbi.2019.108885external icon
- Thrift AP, Gudenkauf FJ. Melanoma incidence among non-Hispanic whites in all 50 United States from 2001 through 2015.external icon Journal of the National Cancer Institute. 2019. 1093/jnci/djz153external icon
- Siegel, DA, Li, J, Ding, H, Singh, SD, King, JB, Pollack, LA. Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United Statesexternal icon. Pediatric Blood and Cancer. 2019;66:e27501. 1002/pbc.27501 external icon
- Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human papillomavirus–attributable cancers—United States, 2012–2016. MMWR Morbidity and Mortality Weekly Report. 2019;68:724–728. 15585/mmwr.mm6833a3external icon
- Scott LC, Barker LE, Richardson LC. Using population health measures to evaluate the environmental burden of cancer at the county level. Preventing Chronic Disease. 2019;16:E45. 5888/pcd16.180530external icon
- Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018.external icon Gastroenterology. 2019;156(1):254-272. 1053/j.gastro.2018.08.063external icon
- Patel N, Benipal B. Incidence of gastrointestinal stromal tumors in the United States from 2001-2015: A United States cancer statistics analysis of 50 States.external icon Cureus. 2019;11(2):e4120. 7759/cureus.4120external icon
- O’Neil ME, Henley SJ, Rohan EA, Ellington TD, Gallaway MS. Lung cancer incidence in nonmetropolitan and metropolitan counties—United States, 2007–2016. MMWR Morbidity and Mortality Weekly Report. 2019;68(44):993–998. 15585/mmwr.mm6844a1external icon
- Melkonian SC, Jim MA, Haverkamp D, Wiggins CL, McCollum J, White MC, Kaur JS, Espey DK. Disparities in cancer incidence and trends among American Indians and Alaska Natives in the United States, 2010–2015external icon. Cancer Epidemiology, Biomarkers and Prevention. 2019;28(10):1604-1611. 1158/1055-9965.EPI-19-0288external icon
- Islami F, Fedewa SA, Jemal A. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.external icon Preventive Medicine. 2019;123:316-323. 1016/j.ypmed.2019.04.010external icon
- Hsu CH, Chan JK, Yin CH, Lee CC, Chern CU, Liao CI. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States.external icon PLoS One. 2019;14(12):e0227197. 1371/journal.pone.0227197external icon
- Hopkins ZH, Moreno C, Carlisle R, Secrest AM. Melanoma prognosis in the United States: Identifying barriers for improved care.external icon Journal of the American Academy of Dermatology, 2019;80(5):1256-1262. 1016/j.jaad.2019.01.003external icon
- Gallaway MS, Berens AS, Puckett MC, Foster S. Understanding geographic variations of indoor radon potential for comprehensive cancer control planning.external icon Cancer Causes Control. 2019;30:707–712. 1007/s10552-019-01162-6external icon
- Eberth JM, Zahnd WE, Adams SA, Friedman DB, Wheeler SB, Hebert JR. Mortality-to-incidence ratios by US Congressional District: Implications for epidemiologic, dissemination and implementation research, and public health policy.external icon Preventive Medicine. 2019. 1016/j.ypmed.2019.105849external icon
- Deshmukh AA, Suk R, Shiels MS, Sonawane K, Nyitray AG, Liu Y, Gaisa MM, Palefsky JM, Sigel K. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015.external icon Journal of the National Cancer Institute. 10.1093/jnci/djz219external icon
- Culp MB, Lunsford NB. Melanoma among non-Hispanic black Americans. Preventing Chronic Disease. 2019;16:180640. 10.5888/pcd16.180640external icon
- Morgenstern H, Longstreth K. Clustering of esophageal cancer among white men in the United States.external icon Diseases of the Esophagus 2019;32(1). 10.1093/dote/doy081external icon
- Mallin K, Browner A, Palis B, Gay G, McCabe R, Nogueira L, Yabroff R, Shulman L, Facktor M, Winchester DP, Nelson H. Incident cases captured in the National Cancer Database compared with those in U.S. population-based central cancer registries in 2012–2014.external icon Annals of Surgical Oncology 2019;26(6):1604–1612. 10.1245/s10434-019-07213-1external icon
- Hopkins ZH, Moreno C, Carlisle R, Secrest AM. Melanoma prognosis in the United States: Identifying barriers for improved care.external icon Journal of the American Academy of Dermatology 2019;80(5) 256–262. 10.1016/j.jaad.2019.01.003external icon
- Guo F, Kuo Y, Berenson AB. Breast cancer incidence by stage before and after change in screening guidelines.external icon American Journal of Preventive Medicine 2019;56(1):100–108. 10.1016/j.amepre.2018.08.018external icon
- Freeman MB, Holman DM, Lunsford NB. Merkel cell carcinoma incidence, trends, and survival rates among adults aged ≥50 years from United States Cancer Statistics.external icon Journal of American Academy of Dermatology 2019;80(4):1154–1156. 10.1016/j.jaad.2018.10.045external icon
- Wang Z, Graham DY, Khan A, Balakrishnan M, Abrams HR, El-Serag HB, Thrift AP. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis.external icon International Journal of Epidemiology 2018;47(3):966–975. 10.1093/ije/dyy055external icon
- Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus-associated cancers—United States, 1999–2015. MMWR 2018;67(33):918–924. 10.15585/mmwr.mm6733a2external icon
- Siegel DA, Li J, Henley SJ, Wilson RJ, Lunsford NB, Tai E, Van Dyne EA. Geographic variation in pediatric cancer incidence—United States, 2003–2014. MMWR 2018;67(25):707–713. 10.15585/mmwr.mm6725a2external icon
- Shoemaker ML, White MC, Wu M, Weir HK, Romieu I. Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013.external icon Breast Cancer Research and Treatment 2018;169(3):595–606. 10.1007/s10549-018-4699-9external icon
- Patel N, Benipal B. Incidence of esophageal cancer in the United States from 2001–2015: A United States Cancer Statistics analysis of 50 states.external icon Cureus 2018;10(12):e3709. 10.7759/cureus.3709external icon
- Melkonian SC, Jim MA, Reilley B, Erdrich J, Berkowitz Z, Wiggins CL, Haverkamp D, White MC. Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999–2009.external icon Cancer Causes & Control 2018;29(9):833–844. 10.1007/s10552-018-1059-3external icon
- Liao CI, Chow S, Chen LM, Kapp DS, Mann A, Chan JK. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the U.S.external icon Gynecologic Oncology 2018;149(2):318–323. 10.1016/j.ygyno.2018.01.030external icon
- Li J, Siegel DA, King JB. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004–2014.external icon Annals of Epidemiology 2018;28(5):328–330. 10.1016/j.annepidem.2018.03.001external icon
- Islami F, Sauer AG, Gapstru SM, Jemal A. Proportion of cancer cases attributable to excess body weight by US state, 2011–2015.external icon JAMA Oncology 2019;5(3):384–392. 10.1001/jamaoncol.2018.5639external icon
- Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I, Flanders WD, Brawley OW, Gapstur SM, Jemal A. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.external icon CA: A Cancer Journal for Clinicians 2018;68(1):31–54. 10.3322/caac.21440external icon
- Houston KA, Mitchell KA, King J, White A, Ryan BM. Histologic lung cancer incidence rates and trends vary by race/ethnicity and residential county.external icon Journal of Thoracic Oncology 2018;13(4):497–509. 10.1016/j.jtho.2017.12.010external icon
- Holman DM, Freeman MB, Shoemaker ML. Trends in melanoma incidence among non-Hispanic whites in the United States, 2005 to 2014.external icon JAMA Dermatology 2018;154(3):361–362. 10.1001/jamadermatol.2017.5541external icon
- Henley SJ, Miller JW, Dowling NF, Benard VB, Richardson LC. Uterine cancer incidence and mortality—United States, 1999–2016. MMWR 2018;67(48)1333–1338. 10.15585/mmwr.mm6748a1external icon
- Guo F, Cofie LE, Berenson AB. Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction.external icon American Journal of Preventive Medicine 2018;55(2):197–204. 10.1016/j.amepre.2018.03.013external icon
- Gopalani S, Janitz AE, Campbell JE. Trends in cervical cancer incidence and mortality in Oklahoma and the United States, 1999–2013.external icon Cancer Epidemiology 2018;56:140–145. 10.1016/j.canep.2018.08.008external icon
- Garcia S, Pruitt S, Singal AG, Murphy CC. Colorectal cancer incidence among Hispanics and non-Hispanic whites in the United States.external icon Cancer Causes & Control 2018;29(11):1039–1046. 10.1007/s10552-018-1077-1external icon
- Gallaway MS, Henley SJ, Steele CB, Momin B, Thomas CC, Jamal A, Trivers KF, Singh SD, Stewart SL. Surveillance of cancers associated with tobacco use—United States, 2010–2014. MMWR Surveillance Summaries 2018;67(12)1–42. 10.15585/mmwr.ss6712a1external icon
- Boscoe F, Hutchison L. Differential reporting of in situ colorectal cancer in New York State and the United States.external icon Journal of Registry Management 2018;45(1):33–36.
- Steele CB, Thomas CC, Henley SJ, Massetti GM, Galuska DA, Agurs-Collins T, Puckett M, Richardson LC. Vital Signs: Trends in incidence of cancers associated with overweight and obesity—United States, 2005–2014. MMWR 2017;66(39):1052–1058. 10.15585/mmwr.mm6639e1external icon
- Singh SD, Henley SJ, Ryerson AB. Surveillance for cancer incidence and mortality—United States, 2013. MMWR Surveillance Summaries 2017;66(4):1–36. 10.15585/mmwr.ss6604a1external icon
- Siegel DA, Henley SJ, Li J, Pollack LA, Van Dyne EA, White A. Rates and trends of pediatric acute lymphoblastic leukemia—United States, 2001–2014. MMWR 2017;66(36):950–954. 10.15585/mmwr.mm6636a3external icon
- Houston KA, King J, Li J, Jemal A. Trends in prostate cancer incidence rates and prevalence of prostate specific antigen screening by socioeconomic status and regions in the United States, 2004 to 2013.external icon The Journal of Urology 2017;199(3):676–682. 10.1016/j.juro.2017.09.103external icon
- Henley SJ, Singh SD, King J, Wilson RJ, O’Neil ME, Ryerson AB. Invasive cancer incidence and survival—United States, 2013. MMWR 2017;66(3):69–75. 10.15585/mmwr.mm6603a1external icon
- Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC. Invasive cancer incidence, 2004–2013, and deaths, 2006–2015, in nonmetropolitan and metropolitan counties—United States. MMWR Surveillance Summaries 2017;66(14):1–13. 10.15585/mmwr.ss6614a1external icon
- Wilson RJ, Ryerson AB, Singh SD, King JB. Cancer incidence in Appalachia, 2004–2011.external icon Cancer Epidemiology, Biomarkers and Prevention 2016;25(2):250–258. 10.1158/1055-9965.EPI-15-0946external icon
- Watson M, Geller AC, Tucker MA, Guy GP Jr, Weinstock MA. Melanoma burden and recent trends among non-Hispanic whites aged 15–49 years, United States.external icon Preventive Medicine 2016;91:294–298. 10.1016/j.ypmed.2016.08.032external icon
- Singh SD, Henley SJ, Ryerson AB. Surveillance for cancer incidence and mortality—United States, 2012. MMWR 2016;63(55):17–58. 10.15585/mmwr.mm6355a4external icon
- Richardson LC, Henley SJ, Miller JW, Massetti G, Thomas CC. Patterns and trends in age-specific black-white differences in breast cancer incidence and mortality—United States, 1999–2014. MMWR 2016;65(40):1093–1098. 10.15585/mmwr.mm6540a1external icon
- Henley SJ, Thomas CC, Sharapova SR, Momin B, Massetti GM, Winn DM, Armour BS, Richardson LC. Vital Signs: Disparities in tobacco-related cancer incidence and mortality—United States, 2004–2013. MMWR 2016;65(44):1212–1218. 10.15585/mmwr.mm6544a3external icon
- Garnett E, Townsend J, Steele B, Watson M. Characteristics, rates, and trends of melanoma incidence among Hispanics in the USA.external icon Cancer Causes and Control 2016;27(5):647–659. 10.1007/s10552-016-0738-1external icon
- Singh SD, Henley SJ, Ryerson AB. Summary of notifiable noninfectious conditions and disease outbreaks: surveillance for cancer incidence and mortality—United States, 2011. MMWR 2015;62(54):11–51. 10.15585/mmwr.mm6254a3external icon
- O’Neil ME, Henley SJ, Singh SD, Wilson RJ, Ortiz-Ortiz KJ, Rios NP, Torres Cintron CR, Luna GT, Zavala Zegarra DE, Ryerson AB, Centers for Disease Control and Prevention. Invasive cancer incidence—Puerto Rico, 2007–2011. MMWR 2015;64(14):389–393.
- Henley SJ, Weir HK, Jim MA, Watson M, Richardson LC. Gallbladder cancer incidence and mortality, United States, 1999–2011.external icon Cancer Epidemiology, Biomarkers and Prevention 2015. 10.1158/1055-9965.EPI-15-0199external icon
- Henley SJ, Singh SD, King J, Wilson RJ, O’Neil ME, Ryerson AB. Invasive cancer incidence and survival—United States, 2012. MMWR 2015;64(49):1353–8. 10.15585/mmwr.mm6449a1external icon
- Henley SJ, Singh SD, King J, Wilson R, O’Neil ME, Ryerson AB, Centers for Disease Control and Prevention. Invasive cancer incidence and survival—United States, 2011. MMWR 2015;64(9):237–242.
- Watson M, Benard V, Thomas C, Brayboy A, Paisano R, Becker T. Cervical cancer incidence and mortality among American Indian and Alaska Native women, 1999–2009.external icon American Journal of Public Health 2014;104(S3):S415–S422. 10.2105/AJPH.2013.301681external icon
- Singh SD, Ryerson AB, Wu M, Kaur JS. Ovarian and uterine cancer incidence and mortality in American Indian and Alaska Native women, United States, 1999–2009.external icon American Journal of Public Health 2014;104(S3):S423–S431. 10.2105/AJPH.2013.301781external icon
- Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J. Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009.external icon Pediatrics 2014;134(4):e945–e955. 10.1542/peds.2013-3926external icon
- King SC, Pollack LA, Li J, King JB, Master VA. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.external icon Journal of Urology 2014. 10.1016/j.juro.2013.12.046external icon
- Houston KA, Henley SJ, Li J, White MC, Richards TB. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009.external icon Lung Cancer 2014;86(1):22–28. 10.1016/j.lungcan.2014.08.001external icon
- Henley SJ, Singh S, King J, Wilson R, Ryerson B, Centers for Disease Control and Prevention. Invasive cancer incidence—United States, 2010. MMWR 2014;63(12):253–259.
- Henley SJ, Richards TB, Underwood JM, Eheman CR, Plescia M, McAfee TA, Centers for Disease Control and Prevention. Lung cancer incidence trends among men and women—United States, 2005–2009. MMWR 2014;63(1):1–5.
- Austin H, Henley SJ, King J, Richardson LC, Eheman C. Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening?external icon Cancer Causes and Control 2014;25(2):191–201. 10.1007/s10552-013-0321-yexternal icon
- Henley SJ, Larson TC, Wu M, Antao VC, Lewis M, Pinheiro GA, Eheman C. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008.external icon International Journal of Occupational and Environmental Health 2013;19(1):1–10. 10.1179/2049396712Y.0000000016external icon
- Duong LM, Richardson LC. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999–2008.external icon Journal of Registry Management 2013;40(2):59–64.
- Drahos J, Wu M, Anderson WF, Trivers KF, King J, Rosenberg PS, Eheman C, Cook MB. Regional variations in esophageal cancer rates by census region in the United States, 1999–2008.external icon PLoS One 2013;8(7):e67913. 10.1371/journal.pone.0067913external icon
- Myles ZM, Buchanan N, King JB, Singh S, White A, Wu M, Ajani U. Anatomic distribution of malignant melanoma on the non-Hispanic black patient, 1998–2007.external icon Archives of Dermatology 2012;148(7):797–801. 10.1001/archdermatol.2011.3227external icon
- Li J, German R, King J, Joseph D, Thompson T, Wu XC, Ajani U, Tai E. Recent trends in prostate cancer testing and incidence among men under age of 50.external icon Cancer Epidemiology 2012;36(2):122–127. 10.1016/j.canep.2011.10.014external icon
- Duong LM, McCarthy BJ, McLendon RE, Dolecek TA, Kruchko C, Douglas LL, Ajani UA. Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004–2007.external icon Cancer 2012;118(17):4220–4227. 10.1002/cncr.27390external icon
- Wu XC, Eide MJ, King J, Saraiya M, Huang Y, Wiggins C, Barnholtz-Sloan JS, Martin N, Cokkinides V, Miller J, Patel P, Ekwueme DU, Kim J. Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999–2006.external icon Journal of the American Academy of Dermatology 2011;65(5S1):S26–37. 10.1016/j.jaad.2011.05.034external icon
- Wong CA, Jim MA, King J, Tom-Orme L, Henderson JA, Saraiya M, Richardson LC, Layne L, Suryaprasad A, Espey DK. Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999–2004.external icon Cancer Causes and Control 2011;22(12):1681–1689. 10.1007/s10552-011-9844-2external icon
- Watson M, Johnson CJ, Chen VW, Thomas CC, Weir HK, Sherman R, Cockburn M, Jackson-Thompson J, Saraiya M. Melanoma surveillance in the United States: overview of methods.external icon Journal of the American Academy of Dermatology 2011;65(5S1):S6–S16. 10.1016/j.jaad.2011.04.037external icon
- Holman DM, Soman A, Watson M, Weir HK, Trivers KF, White MC. Examination of the Increase in Thyroid Cancer Incidence Among Younger Women in the United States by Age, Race, Geography, and Tumor Size, 1999–2007.external icon Journal of Adolescent and Young Adult Oncology 2011;1(2):95–102. 10.1089/jayao.2011.0014external icon
- Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR. Trends in endometrial cancer incidence rates in the United States, 1999–2006.external icon Journal of Women’s Health 2011;20(8):1157–1163. 10.1089/jwh.2010.2529external icon
- Henley SJ, Eheman CR, Richardson LC, Plescia M, Asman KJ, Dube SR, Caraballo RS, McAfee TA. State-specific trends in lung cancer incidence and smoking—United States, 1999–2008. MMWR 2011;60(36):1243–1247.
- Townsend JS, Richardson LC, German RR. Incidence of testicular cancer in the United States, 1999–2004.external icon American Journal of Men’s Health 2010;4(4):353–360. 10.1177/1557988309356101external icon
- Henley SJ, King JB, German RR, Richardson LC, Plescia M, Centers for Disease Control and Prevention. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix)—United States, 2004–2006. MMWR Surveillance Summaries 2010;59(SS09):1-25.
- Centers for Disease Cancer and Prevention. Racial/ethnic disparities and geographic differences in lung cancer incidence—38 states and the District of Columbia, 1998–2006. MMWR 2010;59(44):1434–1438.
- Sabatino SA, Stewart SL, Wilson RJ. Racial and ethnic variations in the incidence of cancers of the uterine corpus, United States, 2001–2003.external icon Journal of Women’s Health) 2009;18(3):285–294. 10.1089/jwh.2008.1171external icon
- Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS. Colorectal cancer incidence in the United States, 1999–2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.external icon Cancer 2009;115(9):1967–1976. 10.1002/cncr.24216external icon
- Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA,White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004.external icon Cancer Epidemiology, Biomarkers and Prevention 2009;18(6):1763–1769. 10.1158/1055-9965.EPI-08-1082external icon
- Duong LM, Ajani UA, Wilson RJ. Comparative evaluation of uterine cancer staging data using two different staging systems, 2001–2005.external icon Journal of Registry Management 2009;36(4):125–129.
- Wingo PA, Tucker TC, Jamison PM, Martin H, McLaughlin C, Bayakly R, Bolick-Aldrich S, Colsher P, Indian R, Knight K, Neloms S, Wilson R, Richards TB. Cancer in Appalachia, 2001–2003.external icon Cancer 2008;112(1):181–192. 10.1002/cncr.23132external icon
- Wingo PA, King J, Swan J, Coughlin SS, Kaur JS, Erb-Alvarez JA, Jackson-Thompson J, Arambula Solomon TG. Breast cancer incidence among American Indian and Alaska Native women: U.S., 1999–2004.external icon Cancer 2008;113(5S):1191–1202. 10.1002/cncr.23725external icon
- Wilson RT, Richardson LC, Kelly JJ, Kaur J, Jim MA, Lanier AP. Cancers of the urinary tract among American Indians and Alaska Natives in the United States, 1999–2004.external icon Cancer 2008;113(5S):1213–1224. 10.1002/cncr.23733external icon
- Wiggins CL, Perdue DG, Henderson JA, Bruce MG, Lanier AP, Kelley JJ, Seals BF, Espey DK. Gastric cancer among American Indians and Alaska Natives in the United States, 1999–2004.external icon Cancer 2008;113(5S):1225–1233. 10.1002/cncr.23732external icon
- Wiggins CL, Espey DK, Wingo PA, Kaur JS, Wilson RT, Swan J, Miller BA, Jim MA, Kelly JJ, Lanier AP. Cancer among American Indians and Alaska Natives in the United States, 1999–2004.external icon Cancer 2008;113(5S):1142–1152. 10.1002/cncr.23734external icon
- Weir HK, Jim MA, Marrett LD, Fairley T. Cancer in American Indian and Alaska Native young adults (ages 20–44 years): U.S., 1999–2004.external icon Cancer 2008;113(5S):1153–1167. 10.1002/cncr.23731external icon
- Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.external icon Cancer 2008;113(10S):2841–2854. 10.1002/cncr.23758external icon
- Trivers KF, Sabatino SA , Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998–2003.external icon International Journal of Cancer 2008;123(6):1422–1428. 10.1002/ijc.23691external icon
- Stewart SL, Cardinez CJ, Richardson LC, Norman L, Kaufmann R, Pechacek TF, Thompson TD, Weir HK, Sabatino SA, Centers for Disease Control and Prevention. Surveillance for cancers associated with tobacco use—United States, 1999–2004. MMWR Surveillance Summaries 2008;57(SS08):1-33.
- Reichman ME, Kelly JJ, Kosary CL, Coughlin SS, Jim MA, Lanier AP. Incidence of cancers of the oral cavity and pharynx among American Indians and Alaska Natives, 1999–2004.external icon Cancer 2008;113(5S):1256–1265. 10.1002/cncr.23735external icon
- Perdue DG, Perkins C, Jackson-Thompson J, Coughlin SS, Ahmed F, Haverkamp DS, Jim MA. Regional differences in colorectal cancer incidence, stage, and subsite among American Indians and Alaska Natives, 1999–2004.external icon Cancer 2008;113(5S):1179–1190. 10.1002/cncr.23726external icon
- Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL. Cancer incidence among children and adolescents in the United States, 2001–2003.external icon Pediatrics 2008;121(6):e1470–e1477. 10.1542/peds.2007-2964external icon
- Lemrow SM, Perdue DG, Stewart SL, Richardson LC, Jim MA, French HT, Swan J, Edwards BK, Wiggins C, Dickie L, Espey DK. Gallbladder cancer incidence among American Indians and Alaska Natives, U.S., 1999–2004.external icon Cancer 2008;113(5S):1266–1273. 10.1002/cncr.23737external icon
- Jim MA, Perdue DG, Richardson LC, Espey DK, Redd JT, Martin HJ, Kwong SL, Kelly JJ, Henderson JA, Ahmed F. Primary liver cancer incidence among American Indians and Alaska Natives, U.S., 1999–2004.external icon Cancer 2008;113(5S):1244–1255. 10.1002/cncr.23728external icon
- Henderson JA, Espey DK, Jim MA, German RR, Shaw KM, Hoffman RM. Prostate cancer incidence among American Indian and Alaska Native men, U.S., 1999–2004.external icon Cancer 2008;113(5S):1203–1212. 10.1002/cncr.23739external icon
- Bliss A, Cobb N, Solomon T, Cravatt K, Jim MA, Marshall L, Campbell J. Lung cancer incidence among American Indians and Alaska Natives in the United States, 1999–2004.external icon Cancer 2008;113(5S):1168–1178. 10.1002/cncr.23738external icon
- Becker TM, Espey DK, Lawson HW, Saraiya M, Jim MA, Waxman AG. Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999–2004.external icon Cancer 2008;113(5S):1234–1243. 10.1002/cncr.23736external icon
- Stewart SL, Wike JM, Foster SL, Michaud F. The incidence of primary fallopian tube cancer in the United States.external icon Gynecologic Oncology 2007;107(3):392–397. 10.1016/j.ygyno.2007.09.018external icon
- Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998–2002.external icon Obstetrics and Gynecology 2007;109(2):362–370. 10.1097/01.AOG.0000254165.92653.e8external icon
- Larson T, Melnikova N, Davis SI, Jamison P. Incidence and descriptive epidemiology of mesothelioma in the United States, 1999–2002.external icon International Journal of Occupational and Environmental Health 2007;13(4):3982–403. 10.1179/oeh.2007.13.4.398external icon
- Stewart SL, Sabatino SA, Foster SL, Richardson LC. Decline in breast cancer incidence—United States, 1999–2003. MMWR 2007;56(22):549–553.
- Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998–2001.external icon Obstetrics and Gynecology 2007;110(3):681–686. 10.1097/01.AOG.0000279449.74780.81external icon
- Wu X, Cokkinides V, Chen VW, Nadel M, Ren Y, Martin J, Ellison GL. Associations of subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis with county-level poverty, by race and sex.external icon Cancer 2006;107(5S):1121–1127. 10.1002/cncr.22009external icon
- Stewart SL, Wike JM, Kato I, Lewis DR, Michaud F. A population-based study of colorectal cancer histology in the United States, 1998–2001.external icon Cancer 2006;107(5S):1128–1141. 10.1002/cncr.22010external icon
- Matanoski G, Tao X, Almon L, Adade AA, Davies-Cole JO. Demographics and tumor characteristics of colorectal cancers in the United States, 1998–2001.external icon Cancer 2006;107(5S):1112–1120. 10.1002/cncr.22008external icon
- Lai SM, Zhang KB, Uhler RJ, Harrison JN, Clutter GG, Williams MA. Geographic variation in the incidence of colorectal cancer in the United States, 1998–2001.external icon Cancer 2006;107(5S):1172–1180. 10.1002/cncr.22014external icon
- Jackson-Thompson J, Ahmed F, German RR, Lai SM, Friedman C. Descriptive epidemiology of colorectal cancer in the United States, 1998–2001.external icon Cancer 2006;107(5S):1103–1111. 10.1002/cncr.22007external icon
- Fairley TL, Cardinez CJ, Martin J, Alley L, Friedman C, Edwards B, Jamison P. Colorectal cancer in U.S. adults younger than 50 years of age, 1998–2001.external icon Cancer 2006;107(5S):1153–1161. 10.1002/cncr.22012external icon
- Coughlin SS, Richards TB, Thompson T, Miller BA, VanEenwyk J, Goodman MT, Sherman RL. Rural/nonrural differences in colorectal cancer incidence in the United States, 1998–2001.external icon Cancer 2006;107(5S):1181–1188. 10.1002/cncr.22015external icon
Page last reviewed: May 4, 2022